13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)

CUSIP No. 269796108
(1)	Names of Reporting Persons Park West Asset Management LLC
(2)	Check the Appropriate Box if a Member of a Group (See Instructions)	(a) ¨ (b) ¨
(3)	SEC Use Only
(4)	Citizenship or Place of Organization Delaware

Number of Shares Beneficially Owned by Each Reporting Person With:	(5) Sole Voting Power	690,000*
	(6) Shared Voting Power	0
	(7) Sole Dispositive Power	690,000*
	(8) Shared Dispositive Power	0

(9)	Aggregate Amount Beneficially Owned by Each Reporting Person 690,000*
(10)	Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions): ¨
(11)	Percent of Class Represented by Amount in Row (9) 4.4%*
(12)	Type of Reporting Person (See Instructions) IA

* Beneficial ownership percentage is based upon 15,589,844 shares of common stock, $0.001 par value per share (“Common Stock”), of Eagle Pharmaceuticals, Inc., a Delaware corporation (the “Company”), issued and outstanding as of November 10, 2015, based on information reported by the Company in its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2015, filed with the Securities and Exchange Commission on November 12, 2015. Park West Asset Management LLC (“PWAM”) is the investment manager to Park West Investors Master Fund, Limited, a Cayman Islands exempted company (“PWIMF”), and Park West Partners International, Limited, a Cayman Islands exempted company (“PWPI” and, collectively with PWIMF, the “PW Funds”), and Peter S. Park (“Mr. Park” and, collectively with PWAM, the “Reporting Persons”) is the sole member and manager of PWAM. As of December 31, 2015, PWIMF held 606,247 shares of Common Stock and PWPI held 83,753 shares of Common Stock of the Company. As a result of the foregoing, for purposes of Reg. Section 240.13d-3, the Reporting Persons may be deemed to beneficially own the 690,000 shares of Common Stock held in the aggregate by the PW Funds, or 4.4% of the shares of Common Stock deemed to be issued and outstanding as of December 31, 2015.

13G Filing: Park West Asset Management and Eagle Pharmaceuticals, Inc. (EGRX)

Published on January 22, 2016 at 3:00 pm by Meena Krishnamsetty in Hedge Funds, News

Page 2 of 9 SEC Filing

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

Follow Eagle Pharmaceuticals Inc. (NASDAQ:EGRX)

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on April 11, 2024 at by Inan Dogan, PhD

50-year Wall Street Insider Names #1 stock for AI “Tidal Wave”

Published on April 1, 2024 at by Insider Monkey Staff